Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
CAREMAX Aktie jetzt für 0€ handeln | |||||
21.02. | CareMax, Inc. - 15-12G, Securities registration termination | - | SEC Filings | ||
10.02. | NSE - CareMax, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | - | SEC Filings | ||
18.11.24 | CareMax Reaches Agreements to Sell Management Services Organization and Core Centers' Assets | 207 | Business Wire | MIAMI--(BUSINESS WIRE)--CareMax, Inc. (NASDAQ: CMAX; CMAXW) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced it has entered into an agreement... ► Artikel lesen | |
09.08.24 | CareMax Reports Second Quarter 2024 Results | 696 | Business Wire | MIAMI--(BUSINESS WIRE)--CareMax, Inc. (NASDAQ: CMAX; CMAXW) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
INTUITIVE SURGICAL | 441,25 | -1,10 % | Opening Bell: Block, Alphabet, Tesla, NextEra Energy, Intuitive Surgical, Constellation Energy | Nachdem die US-Börsen am Freitag zunächst knapp neue Rekordstände erreicht hatten, gaben die Kurse im weiteren Verlauf nach und schlossen weitgehend unverändert. Sowohl der S&P 500 als auch die Nasdaq... ► Artikel lesen | |
UNITEDHEALTH | 241,40 | -0,74 % | Bank-Bilanzen im Fokus - Bitcoin, Nel, United Health, ASML, Goldman Sachs, BoA, Johnson & Johnson | Die Wall Street beendete den gestrigen Handelstag uneinheitlich. Während Standardwerte kaum gefragt waren, sorgte erneut der Technologiebereich für Bewegung. Der Nasdaq 100 stieg zur Eröffnung auf ein... ► Artikel lesen | |
ROKU | 78,13 | -2,67 % | Roku stock rating reiterated at Buy by Benchmark ahead of Q2 earnings | ||
ATOSSA THERAPEUTICS | 0,720 | -0,55 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Windtree Therapeutics: Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel | Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of... ► Artikel lesen | |
CENTENE | 23,580 | -1,93 % | Centene-Aktie verliert 4,01 Prozent (25,1966 €) | Am US-amerikanischen Aktienmarkt liegt der Anteilsschein von Centene gegenwärtig im Minus. Der jüngste Kurs betrug 29,19 US-Dollar. An der Börse liegt der Anteilsschein von Centene derzeit im Minus.... ► Artikel lesen | |
VERU | 0,522 | +1,16 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
QUIDELORTHO | 22,200 | +0,91 % | RBC Capital Maintains a Buy Rating on QuidelOrtho Corporation (QDEL), Sets a $60 PT | ||
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen | |
NANO-X IMAGING | 5,175 | 0,00 % | Nano-X Imaging LTD.: Nanox Announces Clinical and Educational Collaboration with Keiser University Featuring the Nanox.ARC | Nanox.ARC delivers advanced 3D imaging with proprietary cold cathode technologyClinical studies show superior diagnostic performance to X-ray with reduced radiation exposure compared to CT PETACH... ► Artikel lesen | |
FULGENT GENETICS | 15,300 | 0,00 % | Fulgent Genetics gets EU approval for germline sequencing system | ||
LANTHEUS | 60,88 | +0,83 % | Lantheus sinks 8% as CMS wants to maintain reimbursement model for radiopharmaceuticals | ||
PERSPECTIVE THERAPEUTICS | 3,520 | -5,38 % | Perspective Therapeutics, Inc.: Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2025 Financial Results | SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers... ► Artikel lesen | |
AMN HEALTHCARE SERVICES | 15,900 | -7,02 % | AMN Healthcare Announces Sale Of Its Smart Square Scheduling Software | WASHINGTON (dpa-AFX) - AMN Healthcare (AMN) announced the sale of its Smart Square scheduling software to symplr. The total purchase price was $75 million, with $65 million paid at closing
and... ► Artikel lesen | |
OMNICELL | 23,600 | +1,72 % | Wells Fargo raises Omnicell stock price target to $40 on reduced tariff impact |